Pulmonary vascular diseases
State of the art session
Pulmonary vascular diseases
Clinical
Treatment and prevention of severe pulmonary hypertension
Aims : To describe current therapeutic approaches in pulmonary hypertension and to evaluate whether better knowledge of the side effects of drugs can enhance disease prevention.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, Scientist (basic, translational)
16:50
Introduction
1
4757
16:55
Drug-related pulmonary hypertension: new threats?
D. Montani(Le Kremlin-Bicêtre, France)
COI
-
Description
2
4758
17:05
PROs: which instruments are available in pulmonary hypertension?
J. Pepke-Zaba(Cambridge, United Kingdom)
COI
-
Description
3
4759
17:15
The metabolic syndrome and pulmonary hypertension
A. Hemnes(Nashville, United States)
COI
-
Description
4
4760
17:25
Novel insights into the pathogenesis of pulmonary arterial hypertension
M. Humbert(Le Kremlin-Bicêtre, France)
COI
-
Description
5
4761
17:35
Discussion and Q&A
6
4762
. . .